Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Novel-Pack Ltd. is an Israeli biotechnology company that specialized in the development of active packaging and controlled-release delivery systems for the pharmaceutical and food industries. Founded on research from the Hebrew University of Jerusalem, the company utilized a proprietary platform based on hydrocolloid technology to create edible films and coatings. These films were designed to incorporate active pharmaceutical ingredients (APIs) or nutraceuticals, providing protection and controlled release in various environments. The technology aimed to improve the stability and bioavailability of sensitive compounds while offering a novel method for oral or topical delivery. Novel-Pack's solutions addressed the needs for targeted delivery and enhanced shelf-life in both the healthcare and consumer goods sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Novel Pack.